Culture Biosciences Funding: $95M Raised, Series B (2021)
Culture Biosciences is a Biotech company based in San Francisco, CA. It has raised $95M in total funding. Latest round: Series B.
Culture Biosciences funding overview
Culture Biosciences is a Biotech company based in San Francisco, CA. Culture Biosciences has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2021. The round record for Culture Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Cultivian Sandbox Ventures, Verily Life Sciences, Section 32, Y Combinator, E14 Fund, The Production Board. 6 distinct backers are named across the disclosed rounds.
Culture Biosciences at a glance
Total raised
$95M
Latest round
Series B
Latest round date
October 2021
Industry
Biotech
Headquarters
San Francisco, CA
Notable investors
Cultivian Sandbox Ventures, Verily Life Sciences, Section 32, Y Combinator, E14 Fund, The Production Board
Frequently asked about Culture Biosciences funding
How much has Culture Biosciences raised?
Culture Biosciences has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Culture Biosciences?
Cultivian Sandbox Ventures, Verily Life Sciences, Section 32, Y Combinator, E14 Fund, The Production Board are named among the investors backing Culture Biosciences.
What was the latest Culture Biosciences funding round?
The most recent disclosed round is a Series B, announced in October 2021.
Where is Culture Biosciences based?
Culture Biosciences is based in San Francisco, CA.
What sector does Culture Biosciences operate in?
Culture Biosciences is tracked under Biotech from San Francisco, CA, with $95M in disclosed funding.
When did Culture Biosciences last raise?
The last disclosed Culture Biosciences round closed in October 2021 at Series B.
Culture Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Francisco below to benchmark round size and investor mix.
